Basic Information
Lobesity LLC focuses on the clinical and commercial development of breakthrough therapies for obesity and related diseases. Founded in 2015 by M. Michael Wolfe, MD, and Michael O. Boylan, PhD. Our innovative, proprietary anti-GIF monoclonal antibody targets the root causes of obesity.
Lobesity Investors, LLC
Cleveland,Ohio,United States of America
unclear
January 01, 2015
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios